Literature DB >> 28496740

Atrial Fibrillation at an Internal Medicine Ward: Clinical and Prognostic Implications.

Miriam Shteinshnaider1, Dorit Almoznino-Sarafian1, Irena Alon1, Irma Tzur1, Sylvia Berman2, Natan Cohen1, Oleg Gorelik1.   

Abstract

Background: Little is known about atrial fibrillation (AF) appearing during hospitalization in an Internal Medicine ward. Purpose: We aimed to investigate characteristics and prognostic significance of in-hospital onset AF.
Methods: We studied 249 consecutive unselected patients admitted to this medical department with paroxysmal or persistent AF (out-of-hospital group) or AF developed during hospitalization (in-hospital group). Demographic, clinical, laboratory, electrocardiographic and echocardiographic data and all-cause mortality following discharge were recorded and compared between the groups
Results: Diabetes mellitus (p=0.05), renal dysfunction (p<0.001), chronic lung disease (p=0.03) and history of stroke (p=0.01) were found more common in the in-hospital group (56 patients), compared to the out-of-hospital group (193 patients). Patients from the in-hospital group were more likely to have recurrent episodes of AF during hospitalization (p=0.002), were more frequently treated with amiodarone (p<0.001), discharged in sinus rhythm (p=0.04) and with medications for rhythm control (p=0.04). Time from onset to termination of AF (p<0.001) and hospital stay (p<0.001) were longer in the in-hospital group. On a median of 39-months follow-up, survival rate was lower in the in-hospital vs. out-of-hospital group (69.6% vs. 81.3%, p=0.025). Older age was significantly associated with shorter survival in the in-hospital group [odds ratio (OR)=1.87, 95% confidence interval (CI) 1.15-3.03, p=0.009]. In the out-of-hospital group, advanced age (OR=2.17, 95%CI 1.51-3.10, p<0.001), no prior AF episode (OR=3.41, 95%CI 1.56-7.46, p=0.002), diabetes mellitus (OR=2.22, 95%CI 1.12-4.39, p=0.006) and renal dysfunction (OR=2.44, 95%CI 1.10-5.38, p=0.049) were significantly associated with shorter survival.
Conclusion: Patients developing in-hospital AF differed from subjects hospitalized for AF with respect to the severity of the clinical profile and prognosis.

Entities:  

Keywords:  Atrial fibrillation; Hospital; Prognosis; Survival

Year:  2012        PMID: 28496740      PMCID: PMC5153075          DOI: 10.4022/jafib.343

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  29 in total

Review 1.  Amiodarone for atrial fibrillation.

Authors:  Peter Zimetbaum
Journal:  N Engl J Med       Date:  2007-03-01       Impact factor: 91.245

2.  Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience.

Authors:  Mika Lehto; Steven Snapinn; Kenneth Dickstein; Karl Swedberg; Markku S Nieminen
Journal:  Eur Heart J       Date:  2004-12-09       Impact factor: 29.983

3.  Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.

Authors:  Yoko Miyasaka; Marion E Barnes; Bernard J Gersh; Stephen S Cha; Kent R Bailey; Walter P Abhayaratna; James B Seward; Teresa S M Tsang
Journal:  Circulation       Date:  2006-07-03       Impact factor: 29.690

4.  Outcome of patients with newly diagnosed atrial fibrillation at the Mayo Clinic and residing in that area.

Authors:  Philip J Patel; Richard J Keating; Bernard J Gersh; David O Hodge; Stephen C Hammill; Win-Kuang Shen
Journal:  Am J Cardiol       Date:  2004-12-01       Impact factor: 2.778

5.  Relation of C-reactive protein and new-onset atrial fibrillation in patients with acute myocardial infarction.

Authors:  Doron Aronson; Monther Boulos; Abeer Suleiman; Salma Bidoosi; Yoram Agmon; Michael Kapeliovich; Rafael Beyar; Walter Markiewicz; Haim Hammerman; Mahmoud Suleiman
Journal:  Am J Cardiol       Date:  2007-06-12       Impact factor: 2.778

6.  Supraventricular arrhythmia in patients having noncardiac surgery: clinical correlates and effect on length of stay.

Authors:  C A Polanczyk; L Goldman; E R Marcantonio; E J Orav; T H Lee
Journal:  Ann Intern Med       Date:  1998-08-15       Impact factor: 25.391

Review 7.  Pleiotropic effects of statins in atrial fibrillation patients: the evidence.

Authors:  Hadi Ar Hadi; Wael Al Mahmeed; Jassim Al Suwaidi; Samer Ellahham
Journal:  Vasc Health Risk Manag       Date:  2009-06-29

8.  A comparative study of the efficacy and safety of procainamide versus propafenone versus amiodarone for the conversion of recent-onset atrial fibrillation.

Authors:  George E Kochiadakis; Nikos E Igoumenidis; Michail E Hamilos; Maria E Marketou; Gregory I Chlouverakis; Panos E Vardas
Journal:  Am J Cardiol       Date:  2007-04-26       Impact factor: 2.778

Review 9.  Is there a role for statins in atrial fibrillation?

Authors:  David E Dawe; Vignendra Ariyarajah; Aliasghar Khadem
Journal:  Pacing Clin Electrophysiol       Date:  2009-08       Impact factor: 1.976

10.  Long-term prognosis after cardioversion of the first episode of symptomatic atrial fibrillation: a condition believed to be benign revised.

Authors:  Torsten Becker; Thomas Kleemann; Margit Strauss; Klaus Doenges; Steffen Schneider; Jochen Senges; Karlheinz Seidl
Journal:  Clin Res Cardiol       Date:  2007-10-19       Impact factor: 5.460

View more
  1 in total

1.  Screening for atrial fibrillation during automated blood pressure measurement among patients admitted to internal medicine ward.

Authors:  Giacomo Pucci; Edoardo Santoni; Valeria Bisogni; Camilla Calandri; Alberto Cerasari; Irene Dominioni; Leandro Sanesi; Marco D'Abbondanza; Vito Veca; Gaetano Vaudo
Journal:  Intern Emerg Med       Date:  2021-03-20       Impact factor: 3.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.